Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer ...
Dermot Murnaghan spent the final stages of his life campaigning to raise awareness of the lesser-known symptoms of prostate ...
I Have My Life Back” For Mr. Hans W., living with BPH had gradually become more than just a medical condition, it was ...
An enhanced telehealth model demonstrates feasibility and high clinician and patient acceptability for prostate cancer management.
The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. The agency greenlit Merck's Keytruda and its ...
Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...
An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.
British drugmaker GSK said on Friday its experimental drug for treating patients with advanced or relapsed small-cell lung ...
WHO’s Global Status Report on Cancer 2026 warns cancer cases could reach 35 million by 2050. Inequities in diagnosis, ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results